Get intelligentvalue.com

Own it today or select a payment plan

Buy Now$3,879Payment Plan$325/mo

Secured by Stripe

Premium Domain Name

intelligentvalue.com

is available for purchase

51 views

Visitors from

US 54%·

AU 32%·

IN 7%·

GB 2%·

FR 2%

Perfect for

Financial Consulting Technology Startups Educational Services Economic Forecasting E-commerce Solutions Business Analytics Artificial Intelligence Solutions Investment Advisory Strategic Planning Market Research

Unlock the potential of 'intelligentvalue.com', a premium domain that embodies sophistication and expertise in investment advisory and financial consulting. Perfect for businesses in artificial intelligence solutions, market research, and strategic planning, this memorable domain conveys a strong branding message that resonates with clients seeking innovative and data-driven insights. Elevate your presence in the competitive landscape with a digital identity that signifies intelligence, value, and forward-thinking solutions.

Safe & Secure

Protected transactions with Stripe

Fast Transfer

Domain transferred within 24 hours

Flexible Payments

Interest-free payment plans available

3 Cash-Burning Stocks That Concern Us

By: StockStory

April 21, 2026 at 00:34 AM EDT

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

SABR Cover Image

Rapid spending isn’t always a sign of progress. Some cash-burning businesses fail to convert investments into meaningful competitive advantages, leaving them vulnerable.

Not all companies are worth the risk, and that’s why we built StockStory - to help you spot the red flags. That said, here are three cash-burning companies to avoid and some better opportunities instead.

Sabre (SABR)

Trailing 12-Month Free Cash Flow Margin: -6.9%

Originally a division of American Airlines, Sabre (NASDAQ: SABR) is a technology provider for the global travel and tourism industry.

Why Should You Sell SABR?

Sales trends were unexciting over the last five years as its 15.7% annual growth was below the typical consumer discretionary company
Cash-burning tendencies make us wonder if it can sustainably generate shareholder value
7× net-debt-to-EBITDA ratio makes lenders less willing to extend additional capital, potentially necessitating dilutive equity offerings

Sabre’s stock price of $1.93 implies a valuation ratio of 7x forward EV-to-EBITDA. Dive into our free research report to see why there are better opportunities than SABR.

Shoals (SHLS)

Trailing 12-Month Free Cash Flow Margin: -3.4%

Started in Huntsville, Alabama, Shoals (NASDAQ: SHLS) designs and manufactures products that make solar energy systems work more efficiently.

Why Are We Hesitant About SHLS?

Annual sales declines of 1.4% for the past two years show its products and services struggled to connect with the market during this cycle
Earnings per share decreased by more than its revenue over the last two years, showing each sale was less profitable
Eroding returns on capital suggest its historical profit centers are aging

Shoals is trading at $7.25 per share, or 17.2x forward P/E. To fully understand why you should be careful with SHLS, check out our full research report (it’s free).

Integra LifeSciences (IART)

Trailing 12-Month Free Cash Flow Margin: -1.9%

Founded in 1989 as a pioneer in regenerative medicine technology, Integra LifeSciences (NASDAQ: IART) develops and manufactures medical technologies for neurosurgery, wound care, and surgical reconstruction, including regenerative tissue products and surgical instruments.

Why Do We Think IART Will Underperform?

Absence of organic revenue growth over the past two years suggests it may have to lean into acquisitions to drive its expansion
Capital intensity has ramped up over the last five years as its free cash flow margin decreased by 19 percentage points
High net-debt-to-EBITDA ratio of 6× could force the company to raise capital at unfavorable terms if market conditions deteriorate

At $11.16 per share, Integra LifeSciences trades at 4.7x forward P/E. Read our free research report to see why you should think twice about including IART in your portfolio.

Stocks We Like More

WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don't just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.

But our AI platform says the party isn't over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Symbol	Price	Change (%)
AMZN	265.29	+0.00 (0.00%)
AAPL	308.33	+0.00 (0.00%)
AMD	503.89	+0.00 (0.00%)
BAC	52.20	+0.00 (0.00%)
GOOG	384.84	+0.00 (0.00%)
META	612.34	+0.00 (0.00%)
MSFT	416.03	+0.00 (0.00%)
NVDA	214.86	+0.00 (0.00%)
ORCL	193.06	+0.00 (0.00%)
TSLA	433.59	+0.00 (0.00%)